BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $866,040 | +8.3% | 122,322 | +7.7% | 0.01% | +16.7% |
| Q2 2023 | $799,435 | -25.4% | 113,556 | -11.7% | 0.01% | -33.3% |
| Q1 2023 | $1,072,232 | -32.5% | 128,565 | -7.1% | 0.01% | -35.7% |
| Q4 2022 | $1,587,959 | +20.0% | 138,324 | +31.7% | 0.01% | +16.7% |
| Q3 2022 | $1,323,000 | -3.6% | 104,999 | -19.1% | 0.01% | +9.1% |
| Q2 2022 | $1,373,000 | -24.7% | 129,723 | +15.8% | 0.01% | 0.0% |
| Q1 2022 | $1,823,000 | +5.3% | 112,030 | -10.4% | 0.01% | +22.2% |
| Q4 2021 | $1,732,000 | +788.2% | 125,095 | +822.3% | 0.01% | +800.0% |
| Q3 2021 | $195,000 | -93.9% | 13,564 | -94.9% | 0.00% | -87.5% |
| Q4 2014 | $3,222,000 | +44.0% | 264,963 | +15.8% | 0.01% | +60.0% |
| Q3 2014 | $2,237,000 | +559.9% | 228,740 | +760.2% | 0.01% | +400.0% |
| Q2 2014 | $339,000 | +34.0% | 26,591 | +11.2% | 0.00% | 0.0% |
| Q1 2014 | $253,000 | +88.8% | 23,919 | +35.8% | 0.00% | – |
| Q4 2013 | $134,000 | +10.7% | 17,610 | +6.3% | 0.00% | – |
| Q3 2013 | $121,000 | +290.3% | 16,565 | -17.3% | 0.00% | – |
| Q2 2013 | $31,000 | – | 20,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |